Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome

Kee Soo Ha1, Gi Young Jang2, JungHwa Lee3

  • 1Department of Pediatrics, Korea University Guro Hospital, Seoul, Korea.

Insights

Laboratory markers in incomplete Kawasaki disease (iKD) patients show similarities to complete Kawasaki disease (cKD). However, lower hemoglobin levels predict coronary dilation specifically in iKD patients, unlike in cKD.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Infectious Diseases

Background:

  • Kawasaki disease (KD) is a critical pediatric illness affecting blood vessels.
  • Incomplete KD (iKD) presents diagnostic challenges, particularly regarding coronary artery abnormalities.
  • Identifying specific laboratory markers for iKD is crucial for timely intervention.

Purpose of the Study:

  • To define laboratory marker profiles characteristic of iKD.
  • To investigate the association between these markers and coronary artery abnormalities.
  • To compare laboratory findings in iKD, complete KD (cKD), and febrile controls.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 795 patients.
  • Categorization into iKD (178), cKD (504), and febrile controls (113).
  • Evaluation of hemoglobin, platelet counts, and neutrophil-to-lymphocyte ratio over time.

Main Results:

  • Hemoglobin and platelet count trends differed between KD patients (iKD and cKD) and controls.
  • Lower acute and subacute hemoglobin levels were associated with coronary dilation in iKD patients (OR 0.538-0.583).
  • Higher subacute platelet counts (OR 1.004) and acute neutrophil-to-lymphocyte ratio (OR 1.059) were linked to coronary dilation/aneurysm in cKD patients.

Conclusions:

  • iKD patients exhibit KD-specific complete blood cell count and acute phase reactant profiles similar to cKD patients.
  • Predictors of coronary dilation vary between iKD and cKD phenotypes.
  • Lower hemoglobin levels are a significant predictor of coronary dilation exclusively in iKD patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
519
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
302
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
422
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
734
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
30.1K